Fatigue is highly prevalent in patients with COPD and correlates poorly with the degree of airflow limitation

Therapeutic Advances in Respiratory Disease

Volumn 13, Issue , 2019, Pages

  Goërtz, Yvonne M J ^a   Spruit, Martijn A ^a   Van ‘t Hul, Alex J ^b   Peters, Jeannette B ^b   Van Herck, Maarten ^c   Nakken, Nienke ^a   Djamin, Remco S ^d   Burtin, Chris ^c   Thong, Melissa S Y ^e   Coors, Arnold ^b   Meertens Kerris, Yvonne ^f   Wouters, Emiel F M ^a   Prins, Judith B ^b   Franssen, Frits M E ^a   Muris, Jean W M ^g   Vanfleteren, Lowie E G W ^a   Sprangers, Mirjam A G ^e   Janssen, Daisy J A ^a   Vercoulen, Jan H ^b  

^a Centre of Expertise for Chronic Organ Failure   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c HASSELT UNIVERSITY   (Belgium)

^d AMPHIA HOSPITAL   (Netherlands)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f Centre of Expertise for Chronic Organ Failure   (Netherlands)

^g MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

airway obstruction; chronic obstructive pulmonary disease; fatigue

Indexed keywords

AGED; AIRFLOW; ARTICLE; BODY COMPOSITION; CHARLSON COMORBIDITY INDEX; CHECKLIST; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; CROSS-SECTIONAL STUDY; DEMOGRAPHY; FATIGUE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GOLD STANDARD; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; QUESTIONNAIRE; REGRESSION ANALYSIS; SPIROMETRY; CASE CONTROL STUDY; CLINICAL TRIAL; LUNG; MIDDLE AGED; MULTICENTER STUDY; NETHERLANDS; OBSERVATIONAL STUDY; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SEVERITY OF ILLNESS INDEX; VITAL CAPACITY;

AGED; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FATIGUE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; MALE; MIDDLE AGED; NETHERLANDS; OBSERVATIONAL STUDIES AS TOPIC; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VITAL CAPACITY;

EID: 85072706422     PISSN: 17534658     EISSN: 17534666     Source Type: Journal    
DOI: 10.1177/1753466619878128     Document Type: Article

References (59)

1. Bultmann U, Kant I, Kasl SV,. Fatigue and psychological distress in the working population: psychometrics, prevalence, and correlates. J Psychosom Res 2002; 52: 445–452.
2. Chen MK., The epidemiology of self-perceived fatigue among adults. Prev Med 1986; 15: 74–81.
3. Loge JH, Ekeberg O, Kaasa S., Fatigue in the general Norwegian population: normative data and associations. J Psychosom Res 1998; 45: 53–65.
4. Pawlikowska T, Chalder T, Hirsch SR,. Population based study of fatigue and psychological distress. BMJ 1994; 308: 763–766.
5. Ream E, Richardson A., Fatigue in patients with cancer and chronic obstructive airways disease: a phenomenological enquiry. Int J Nurs Stud 1997; 34: 44–53.
6. Janson-Bjerklie S, Carrieri VK, Hudes M., The sensations of pulmonary dyspnea. Nurs Res 1986; 35: 154–159.
7. Blinderman CD, Homel P, Billings JA,. Symptom distress and quality of life in patients with advanced chronic obstructive pulmonary disease. J Pain Symptom Manag 2009; 38: 115–123.
8. Walke LM, Byers AL, Tinetti ME,. Range and severity of symptoms over time among older adults with chronic obstructive pulmonary disease and heart failure. Archiv Intern Med 2007; 167: 2503–2508.
9. Kapella MC, Larson JL, Patel MK,. Subjective fatigue, influencing variables, and consequences in chronic obstructive pulmonary disease. Nurs Res 2006; 55: 10–17.
10. Stridsman C, Skar L, Hedman L,. Fatigue affects health status and predicts mortality among subjects with COPD: report from the population-based OLIN COPD study. COPD 2015; 12: 199–206.
11. Kouijzer M, Brusse-Keizer M, Bode C., COPD-related fatigue: impact on daily life and treatment opportunities from the patient’s perspective. Respir Med 2018; 141: 47–51.
12. Stridsman C, Svensson M, Strandkvist VJ,. The COPD Assessment Test (CAT) can screen for fatigue among patients with COPD. Ther Adv Respir Dis 2018; 12: L1–L10.
13. Kentson M, Todt K, Skargren E,. Factors associated with experience of fatigue, and functional limitations due to fatigue in patients with stable COPD. Ther Adv Respir Dis 2016; 10: 410–424.
14. Theander K, Unosson M., Fatigue in patients with chronic obstructive pulmonary disease. J Adv Nurs 2004; 45: 172–177.
15. Gift AG, Shepard CE., Fatigue and other symptoms in patients with chronic obstructive pulmonary disease: do women and men differ? JOGNN 1999; 28: 201–208.
16. Peters JB, Heijdra YF, Daudey L,. Course of normal and abnormal fatigue in patients with chronic obstructive pulmonary disease, and its relationship with domains of health status. Patient Educ Couns 2011; 85: 281–285.
17. Inal-Ince D, Savci S, Saglam M,. Fatigue and multidimensional disease severity in chronic obstructive pulmonary disease. Multidiscip Respir Med 2010; 5: 162–167.
18. Baghai-Ravary R, Quint JK, Goldring JJ,. Determinants and impact of fatigue in patients with chronic obstructive pulmonary disease. Respir Med 2009; 103: 216–223.
19. Lewko A, Bidgood PL, Garrod R., Evaluation of psychological and physiological predictors of fatigue in patients with COPD. BMC Pulm Med 2009; 9: 47.
20. Andersson M, Stridsman C, Ronmark E,. Physical activity and fatigue in chronic obstructive pulmonary disease: a population based study. Respir Med 2015; 109: 1048–1057.
21. Janssen DJ, Spruit MA, Uszko-Lencer NH,. Symptoms, comorbidities, and health care in advanced chronic obstructive pulmonary disease or chronic heart failure. J Palliat Med 2011; 14: 735–743.
22. Spruit MA, Vercoulen JH, Sprangers MAG,. Fatigue in COPD: an important yet ignored symptom. Lancet Respir Med 2017; 5: 542–544.
23. Breukink SO, Strijbos JH, Koorn M,. Relationship between subjective fatigue and physiological variables in patients with chronic obstructive pulmonary disease. Respir Med 1998; 92: 676–682.
24. Breslin E, van der Schans C, Breukink S,. Perception of fatigue and quality of life in patients with COPD. Chest 1998; 114: 958–964.
25. Postma DS, Wijkstra PJ, Hiemstra PS,. The Dutch National Program for Respiratory Research. Lancet Respir Med 2016; 4: 356–357.
26. Nakken N, Janssen DJ, van den Bogaart EH,. An observational, longitudinal study on the home environment of people with chronic obstructive pulmonary disease: the research protocol of the Home Sweet Home study. BMJ Open 2014; 4: e006098.
27. Vercoulen JH, Daudey L, Molema J,. An Integral assessment framework of health status in chronic obstructive pulmonary disease (COPD). Int J Behav Med 2008; 15: 263–279.
28. Van den Akker EF, Van‘t Hul AJ, Chavannes NH,. Development of an integral assessment approach of health status in patients with obstructive airway diseases: the CORONA study. Int J Chron Obstruct Pulmon Dis 2015; 10: 2413–2422.
29. Smid DE, Spruit MA, Deeg DJH,. How to determine an impaired health status in COPD: Results from a population-based study. Neth J Med 2017; 75: 151–157.
30. Koolen EH, Van Hees HW, Van Lummel RC,. ‘Can do’ versus ‘do do’: a novel concept to better understand physical functioning in patients with chronic obstructive pulmonary disease. J Clin Med 2019; 8.
31. Global Initiative for Chronic Obstructive Lung Disease. From the Global Strategy fort he diagnosis, management and prevention of COPD, http://www.goldcopd.org/ (accessed 27 October 2017).
32. Vercoulen JH, Swanink CM, Fennis JF,. Dimensional assessment of chronic fatigue syndrome. J Psychosom Res 1994; 38: 383–392.
33. Beurskens AJ, Bultmann U, Kant I,. Fatigue among working people: validity of a questionnaire measure. Occup Environ Med 2000; 57: 353–357.
34. Bultmann U, De Vries M, Beurskens AJ,. Measurement of prolonged fatigue in the working population: determination of a cutoff point for the checklist individual strength. J Occup Health Psychol 2000; 5: 411–416.
35. Worm-Smeitink M, Gielissen M, Bloot L,. The assessment of fatigue: psychometric qualities and norms for the Checklist individual strength. J Psychosom Res 2017; 98: 40–46.
36. Repping-Wuts H, Fransen J, van Achterberg T,. Persistent severe fatigue in patients with rheumatoid arthritis. J Clin Nurs 2007; 16: 377–383.
37. Servaes P, Gielissen MF, Verhagen S,. The course of severe fatigue in disease-free breast cancer patients: a longitudinal study. Psycho-oncology 2007; 16: 787–795.
38. Van Herck M, Spruit MA, Burtin C,. Fatigue is highly prevalent in patients with asthma and contributes to the burden of disease. J Clin Med 2018; 23: E471.
39. Charlson ME, Pompei P, Ales KL,. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987; 40: 373–383.
40. Schols AM, Ferreira IM, Franssen FM,. Nutritional assessment and therapy in COPD: a European Respiratory Society statement. Eur Respir J 2014; 44: 1504–1520.
41. Rodriguez-Roisin R., Toward a consensus definition for COPD exacerbation. Chest 2000; 117: 398s–401s.
42. Mahler DA, Wells CK., Evaluation of clinical methods for rating dyspnea. Chest 1988; 93: 580–586.
43. Miller MR, Hankinson J, Brusasco V,. Standardisation of spirometry. Eur Respir J 2005; 26: 319–338.
44. Rabe KF, Hurd S, Anzueto A,. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532–555.
45. Cohen J., Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale: NJ, Erlbaum, 1988.
46. Goertz YMJ, Looijmans M, Prins JB,. Fatigue in patients with chronic obstructive pulmonary disease: protocol of the Dutch multicentre, longitudinal, observational FAntasTIGUE study. BMJ Open 2018; 8: e021745.
47. Reishtein JL., Relationship between symptoms and functional performance in COPD. Res Nurs Health 2005; 28: 39–47.
48. Woo K., A pilot study to examine the relationships of dyspnoea, physical activity and fatigue in patients with chronic obstructive pulmonary disease. J Clin Nurs 2000; 9: 526–533.
49. Kinsman RA, Yaroush RA, Fernandez E,. Symptoms and experiences in chronic bronchitis and emphysema. Chest 1983; 83: 755–761.
50. Hanania NA, Mullerova H, Locantore NW,. Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med 2011; 183: 604–611.
51. Biswas D, Mukherjee S, Chakroborty R,. Occurrence of anxiety and depression among stable COPD patients and its impact on functional capability. J Clin Diagn Res 2017; 11: OC24–OC27.
52. Economou N-T, Ilias I, Velentza L,. Sleepiness, fatigue, anxiety and depression in Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea – Overlap – Syndrome, before and after continuous positive airways pressure therapy. PLoS One 2018; 13: e0197342.
53. Vardar-Yagli N, Calik-Kutukcu E, Saglam M,. The relationship between fear of movement, pain and fatigue severity, dyspnea level and comorbidities in patients with chronic obstructive pulmonary disease. Disabil Rehabil 2018; 10: 1–5.
54. Stridsman C, Müllerova H, Skär L,. Fatigue in COPD and the impact of respiratory symptoms and heart disease: a population based study. COPD 2013; 10: 12–132.
55. Vanfleteren LE, Spruit MA, Groenen M,. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013; 187: 728–735.
56. Matura LA, Malone S, Jaime-Lara R,. A systematic review of biological mechanisms of fatigue in chronic illness. Biol Res Nurs 2018; 20: 410–421.
57. Al-Shair K, Kolsum U, Dockry R,. Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD. Respir Res 2011; 12: 3.
58. Larson R, Csikszentmihalyi M. The experience sampling method. In: Reis HT, (ed.) Naturalistic approaches to studying social interaction: new directions for naturalistic methods in the behavioral sciences. Vol. 15. San Francisco, CA: Jossey-Bass, 1983, pp.41–56.
59. Maes IH, Delespaul PA, Peters ML,. Measuring health-related quality of life by experiences: the experience sampling method. Value Health 2015; 18: 44–51.